• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Pain (1994); Stenosis (2263); Obstruction/Occlusion (2422)
Event Date 01/23/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
The patient presented with an aneurysm within the popliteal artery which was intended to be treated with two gore® viabahn® endoprostheses on (b)(6) 2017.It was stated that a 5mm x 10cm device was implanted at the distal end of the aneurysm and a 6mm x 10cm device implanted at the proximal end.After both medical devices have been implanted successfully, with an appropriate overlapping and good blood flow, the patient was discharged from the hospital.On (b)(6) 2018, the patient presented with pain in the treated leg where a performed angiography indicated a migration of the two implanted gore® viabahn® endoprostheses for about 3 cm distal.It was reported to gore that due to the device migration, the distal gore® viabahn® endoprosthesis covered the anterior tibial artery which resulted in a major thrombosis of the patients leg.An attempt was made to perform a recanalization of the thrombus which resulted in an open surgery where the distal implanted gore® viabahn® endoprosthesis was removed from the artery and the treatment was completed by performing a bypass procedure.It was stated that the patient was doing well following the procedure.
 
Manufacturer Narrative
Engineering evaluation: an expanded gore® viabahn® endoprostheses was returned and evaluated.The endoprosthesis measured approximately 8.4 cm in length and 0.5 cm in diameter.The distal (straight) end of the endoprosthesis appeared to have some delamination of the graft from the stent.It also appears that the distal stent row is folded into graft.After pulling the inverted part out, it was able to be seen that there was an incomplete stent row.It appeared that the straight end of the stent graft had been cut/ripped.Based on the device examination performed, no manufacturing anomalies were identified.
 
Manufacturer Narrative
Added conclusion code (b)(4).
 
Manufacturer Narrative
An explant evaluation was performed for the 5mm x 10cm gore® viabahn® endoprosthesis, which was implanted at the distal end of the aneurysm and which migrated for about 3 cm resulted in a covered the anterior tibial artery and consequently caused a thrombosis of the patients leg.Submitted unfixed and devoid of tissue was one gore® viabahn® endoprosthesis fragment.The lumen of the device was widely patent.One pole was transected prior to arrival, with graft material and wire missing.Histopathological examination was not performed due to the paucity of adherent tissue.The device fragment was subjected to an enzymatic digestion process to remove biologic debris.Following digestion the fragment was examined for material disruptions with the aid of a stereomicroscope.The device was transected at the distal end with the ptfe presenting unevenly discontinuous and bound by smooth edges and the stent frame surface had disruptions (e.G., scratches) and faces of the wire ends were markedly angled: these disruptions are consistent with the use of a sharp surgical instrument likely used during the surgical explant process (e.G., scissors).No wear related disruptions were identified.The previous reported coding remains the unchanged based on the investigations results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7543649
MDR Text Key109227562
Report Number2017233-2018-00304
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup,Followup
Report Date 03/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/23/2018
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/25/2018
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received06/28/2018
02/18/2019
03/01/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age61 YR
-
-